Activités à venir

This educational initiative was developed to provide a forum for discussing and presenting laboratory and clinical research concerning the care of patients through case based coronary and structural heart intervention cases. This initiative strives to help those treating cardiology patients with the latest updates.

The Summit will kick off with an update on the current standard of care and management of patients with cardiovascular disease. The next day and a half will highlight recent advances in clinical medicine including 3D modelling and surgical repair. Also addressed will be how catheter interventions have improved outcomes for patients with congenital heart disease including congenitally corrected transposition of the great arteries (CCTGA). The Summit will incorporate team-based management of complex congenital heart disease and review the importance of avoiding authority gradients, communication, feedback, and mutual understanding.

The Eastern Cardiothoracic Surgical Society was founded in 1963. Our mission is to encourage and stimulate investigation and study that will increase the knowledge of intrathoracic physiology, pathology, and therapy.

For the first time in history, patients born with congenital heart disease are surviving and even thriving in adulthood, many with a normal life expectancy. As a relatively new patient population, many individuals are lost in the system as they transition from pediatrics to an adult physician. Recognizing this challenge, Houston Methodist DeBakey Institute of Cardiovascular Education & Training will be holding its fifth annual Adult Congenital Heart (ACH) Symposium. This popular annual event is a unique opportunity for patients, family, caregivers and their physicians to learn more about care and treatment options from leading ACH experts.

The purpose of this educational activity is to provide a current review of new information on the basic pathophysiology of ventricular arrhythmias. It is also designed to provide an in-depth understanding of the various management strategies that are currently being developed for the management of ventricular arrhythmias in various disease states, including non-pharmacologic therapies such as implantable device therapy and advances in catheter ablation techniques.

This 1.5-day symposium will provide an opportunity for leaders in electrophysiology (EP) research and clinical practice to interact in a forum which will encourage an open discussion of research, challenges, and future directions in EP. The prestigious international faculty will focus on global issues and the latest EP developments, encouraging innovation and collaboration. Discussions on current changes in the healthcare environment and how these changes affect clinical practice will be included.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Now in its 31st year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.

Enhance your transseptal skill set and interpretation of multimodality imaging for left-sided structural heart interventions by attending interactive workshops offered on September 26th & 27th. Expert faculty will provide didactic learning, followed by hands-on application using simulators, dry models and devices.

PRE-REGISTRATION REQUIRED

Thursday September 26th
Multimodality Imaging for Transseptal Crossing and LAAC
Location: CRF Pavilion 2
Times: 8:00-9:30am; 12:00-1:30pm; 4:00-5:30pm

Friday September 27th
Transseptal Hands-On Training Program
Location: Boston Scientific Pavilion
Times: 12:00-1:30pm; 4:00-5:30pm

Rassemblée sur 5 demi-journées, cette manifestation aborde l’essentiel des thèmes de la stimulation, de la défibrillation et de la rythmologie à la fois en séances plénières et en ateliers pratiques.

This one-day symposium provides a comprehensive update on the long-term issues faced by adult Fontan survivors. The course focuses on patients with “failing” Fontan physiology and the available tools and therapies for the treatment of this challenging subset of patients, including updates on medical therapies, catheter-based and surgical techniques for palliation and support. The ultimate therapeutic options of orthotopic heart and multi-organ transplantation are covered in detail as the need grows in this aging Fontan population. The target audience includes adult and pediatric congenital cardiologists, congenital and transplant cardiac surgeons, heart failure/transplant specialists, hepatologists, liver transplant surgeons, cardiac intensivists, cardiology and cardiac surgery trainees, cardiac nurses, nurse practitioners, and physician assistants.